AIVOCODE, INC.

Biotech · Private

Single domain antibodies against connective tissue growth factor (CTGF) for Alzheimer's disease

aivocode.com →
Grants
$1.1M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: A Novel Platform to Enable Directed Delivery of Therapeutics into Brain Injuries$149,757
Federal grantNational Science Foundation · Phase II · SBIR Phase II: A Novel Platform to Enable Directed Delivery of Therapeutics into Brain Injuries$981,925
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3040GENETOBE INC——
3041DISCOVERY GENOMICS, INC.——
3042TOPOGENE, INC.——
3043AIVOCODE, INC.——
3044Panorama Research Incorporated——
3045E&E BIOCLUB LLC——
3046VIRONIKA LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.